Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Beckly

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
BMJ (Clinical Research Ed.)|October 25, 2002
Probiotics and antibiotic associated diarrhoea. The case for probiotics remains unprovedJohn Beckly, Stephen Lewis
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 25, 2003
The man who gained a stoneJohn Beckly, Sunil Bhandari, Josette Eris, et al.
Inflammatory Bowel Diseases|February 25, 2009
Association between genetic variants in myosin IXB and Crohn's diseaseRachel Cooney, J R Fraser Cummings, Saad Pathan, et al.
Journal of Crohn'S & Colitis|September 30, 2017
Corrigendum: Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel DiseaseGraham A Heap, Kenji So, Mike Weedon, et al.
Inflammatory Bowel Diseases|June 4, 2008
Clinical and molecular characteristics of isolated colonic Crohn's diseaseLaura Hancock, John Beckly, Alessandra Geremia, et al.
Inflammatory Bowel Diseases|May 18, 2007
Contribution of the novel inflammatory bowel disease gene IL23R to disease susceptibility and phenotypeJ R Fraser Cummings, Tariq Ahmad, Alessandra Geremia, et al.
Inflammatory Bowel Diseases|April 25, 2007
Confirmation of the role of ATG16L1 as a Crohn's disease susceptibility geneJ R Fraser Cummings, Rachel Cooney, Saad Pathan, et al.
European Journal of Gastroenterology & Hepatology|December 23, 2011
The management of low-risk primary upper gastrointestinal haemorrhage in the community: a 5-year observational studyCara McLaughlin, Louisa Vine, Luke Chapman, et al.
Journal of Crohn'S & Colitis|December 2, 2015
Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel DiseaseGraham A Heap, Kenji So, Mike Weedon, et al.
Alimentary Pharmacology & Therapeutics|August 30, 2022
Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring studyNeil Chanchlani, Simeng Lin, Marcus K Auth, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
BMJ (Clinical Research Ed.)|October 25, 2002
Probiotics and antibiotic associated diarrhoea. The case for probiotics remains unprovedJohn Beckly, Stephen Lewis
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 25, 2003
The man who gained a stoneJohn Beckly, Sunil Bhandari, Josette Eris, et al.
Inflammatory Bowel Diseases|February 25, 2009
Association between genetic variants in myosin IXB and Crohn's diseaseRachel Cooney, J R Fraser Cummings, Saad Pathan, et al.
Journal of Crohn'S & Colitis|September 30, 2017
Corrigendum: Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel DiseaseGraham A Heap, Kenji So, Mike Weedon, et al.
Inflammatory Bowel Diseases|June 4, 2008
Clinical and molecular characteristics of isolated colonic Crohn's diseaseLaura Hancock, John Beckly, Alessandra Geremia, et al.
Inflammatory Bowel Diseases|May 18, 2007
Contribution of the novel inflammatory bowel disease gene IL23R to disease susceptibility and phenotypeJ R Fraser Cummings, Tariq Ahmad, Alessandra Geremia, et al.
Inflammatory Bowel Diseases|April 25, 2007
Confirmation of the role of ATG16L1 as a Crohn's disease susceptibility geneJ R Fraser Cummings, Rachel Cooney, Saad Pathan, et al.
European Journal of Gastroenterology & Hepatology|December 23, 2011
The management of low-risk primary upper gastrointestinal haemorrhage in the community: a 5-year observational studyCara McLaughlin, Louisa Vine, Luke Chapman, et al.
Journal of Crohn'S & Colitis|December 2, 2015
Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel DiseaseGraham A Heap, Kenji So, Mike Weedon, et al.
Alimentary Pharmacology & Therapeutics|August 30, 2022
Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring studyNeil Chanchlani, Simeng Lin, Marcus K Auth, et al.
Pageof 1